Sarah McNeill was a visiting student at the Centre for Evidence Based Medicine, Oxford and a postgraduate at the Australian National University, Canberra. She worked on the Open Trials and Trial Tracker projects with the Bennett Institute. She completed her undergraduate degree at the University of Sydney with a double major in French and Neuroscience. Before coming to Oxford Sarah was an intern at the World Health Organization in Geneva. She has had a (vested) interest in EBM since receiving experimental corticosteroid therapy in utero, the efficacy of which can now be seen in the Cochrane logo.